Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy ResistanceAlex Pearson, Nicholas C. Turner, Paula Proszek et al.|Clinical Cancer Research|2019Cited by 137
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Cancer Research|2023Cited by 15
Supplementary Fig. S4 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0
Figure 7 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Minyue Chen et al.|Unknown|2023Cited by 0
Figure 5 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0